Proton (1H) MR spectroscopy of the breast

Radiographics : a Review Publication of the Radiological Society of North America, Inc
Lia Bartella, Wei Huang

Abstract

Proton (hydrogen 1) [1H]) magnetic resonance (MR) spectroscopy provides biochemical information about the tissue under investigation. Its diagnostic value in cancer is typically based on the detection of elevated levels of choline compounds, choline being a marker of active tumor. The two main potential clinical applications of 1H MR spectroscopy are (a) as an adjunct to breast MR imaging to improve specificity in differentiating benign from malignant lesions, and (b) for monitoring or even predicting response to treatment in patients undergoing neoadjuvant chemotherapy. Preliminary data are promising, with study results suggesting that 1H MR spectroscopy may decrease the number of benign biopsies recommended on the basis of MR imaging findings and may help predict response as early as 24 hours after the first dose of neoadjuvant chemotherapy. Although several limitations currently exist that make the technique premature for clinical use, further evaluation with larger, preferably multicenter trials is certainly warranted.

References

Sep 1, 1992·NMR in Biomedicine·W Negendank
Oct 14, 1998·Radiology·J R RoebuckR E Lenkinski
Dec 16, 1998·Journal of Magnetic Resonance Imaging : JMRI·I S GribbestadP A Rinck
Aug 10, 1999·Journal of Magnetic Resonance Imaging : JMRI·K A KvistadO Haraldseth
Mar 7, 2000·Journal of the American College of Surgeons·H M KuererS E Singletary
Jul 28, 2001·Seminars in Roentgenology·E A Morris
Aug 22, 2002·Journal of the National Cancer Institute·Rachel Katz-BrullRobert E Lenkinski
Aug 23, 2003·AJR. American Journal of Roentgenology·Elizabeth A MorrisD David Dershaw
Dec 4, 2003·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Patrick J BolanMichael Garwood
Dec 30, 2003·Journal of Magnetic Resonance Imaging : JMRI·Michael A JacobsDavid A Bluemke
Jul 30, 2004·The New England Journal of Medicine·Laura Liberman
Sep 8, 2004·European Radiology·Peter StanwellCarolyn Mountford
Sep 16, 2004·JAMA : the Journal of the American Medical Association·Mark E Robson, Kenneth Offit
Dec 24, 2005·Radiology·Mitchell D SchnallConstantine A Gatsonis
Feb 25, 2006·AJR. American Journal of Roentgenology·Lia BartellaD David Dershaw

❮ Previous
Next ❯

Citations

Sep 16, 2010·Der Radiologe·K PinkerT H Helbich
Apr 30, 2008·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Mitsuhiro Tozaki
Dec 4, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Donald G RobertsonMichael D Reily
Mar 7, 2014·Journal of Cancer Research and Clinical Oncology·Dongzhi Cen, Li Xu
Jun 7, 2014·European Radiology·Jie ZhangYuanyuan Zong
Apr 21, 2011·Archives of Gynecology and Obstetrics·Doerte W LueddersMichael K Bohlmann
Mar 15, 2013·European Journal of Radiology·Ahmed Abdel Khalek Abdel Razek, Harish Poptani
Feb 12, 2014·Magnetic Resonance Imaging·Junfeng Li, Xiaowei Han
Jun 18, 2010·European Journal of Radiology·K PinkerT H Helbich
May 2, 2009·Magnetic Resonance Imaging Clinics of North America·Marianne MoonJeffrey Weinreb
Jan 4, 2012·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Rani G SahNaranamangalam R Jagannathan
Mar 15, 2011·Journal of Surgical Oncology·Vanessa W DavisMichael B Sawyer
Sep 28, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jieying TanSherman Xuegang Xin
Apr 23, 2009·Molecular Oncology·Leonard Fass
Nov 12, 2016·Cancer Gene Therapy·Z SaadatpourH Mirzaei
Nov 3, 2016·The British Journal of Radiology·Katja PinkerElizabeth A Morris
Jan 1, 2013·Metabolites·Richard D Beger
Sep 21, 2017·Acta Radiologica·Sigmund Ytre-HaugeIngfrid S Haldorsen
Nov 15, 2016·Frontiers in Oncology·Francesco SardanelliRubina Manuela Trimboli
Nov 20, 2016·Cancer Gene Therapy·Z SaadatpourM Keshavarzi
Dec 30, 2016·NMR in Biomedicine·Wybe J M van der KempJannie P Wijnen
Feb 21, 2014·Expert Review of Anticancer Therapy·Heinrich Florian MagometschniggKatja Pinker
Jul 2, 2019·BJR Open·Uma Sharma, Naranamangalam Raghunathan Jagannathan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.